Vanguard Group Inc Opgen Inc Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.12 - $62.0 $169,312 - $87.5 Million	-1,410,941 Reduced 75.15%	466,656 $65,000
Q3 2022 Nov 14, 2022	BUY	$0.39 - $78.8 $208,634 - $42.2 Million	534,960 Added 39.84%	1,877,597 $537,000
Q1 2022 May 13, 2022	SELL	$0.72 - $1.11 $141,967 - $218,866	-197,177 Reduced 12.81%	1,342,637 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.94 $3,596 - $10,572	3,596 Added 0.23%	1,539,814 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$2.18 - $3.58 $337,923 - $554,939	155,011 Added 11.22%	1,536,218 $4.43 Million
Q2 2021 Aug 13, 2021	BUY	$1.95 - $2.8 $2.69 Million - $3.87 Million	1,381,207 New	1,381,207 $3.14 Million

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.